Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) High Throughput Screening Market Research Report 2019-2025

Buy now
  • 1.1 Research Scope
  • 1.2 Market Segmentation
  • 1.3 Research Objectives
  • 1.4 Research Methodology
    • 1.4.1 Research Process
    • 1.4.2 Data Triangulation
    • 1.4.3 Research Approach
    • 1.4.4 Base Year
  • 1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
    • 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
    • 1.5.2 Covid-19 Impact: Commodity Prices Indices
    • 1.5.3 Covid-19 Impact: Global Major Government Policy
  • 1.6 The Covid-19 Impact on High Throughput Screening Industry
  • 1.7 COVID-19 Impact: High Throughput Screening Market Trends
  • 2 Global High Throughput Screening Quarterly Market Size Analysis

    • 2.1 High Throughput Screening Business Impact Assessment - COVID-19
      • 2.1.1 Global High Throughput Screening Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
    • 2.2 Global High Throughput Screening Quarterly Market Size 2020-2021
    • 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
      • 2.3.1 Drivers
      • 2.3.2 Restraints
      • 2.3.3 Opportunities
      • 2.3.4 Challenges

    3 Quarterly Competitive Assessment, 2020

    • 3.1 By Players, Global High Throughput Screening Quarterly Market Size, 2019 VS 2020
    • 3.2 By Players, High Throughput Screening Headquarters and Area Served
    • 3.3 Date of Key Players Enter into High Throughput Screening Market
    • 3.4 Key Players High Throughput Screening Product Offered
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Impact of Covid-19 on High Throughput Screening Segments, By Type

    • 4.1 Introduction
      • 1.4.1 Cell-based Assays
      • 1.4.2 Lab-On-A-Chip
      • 1.4.3 Ultra-High-Throughput Screening
      • 1.4.4 Bioinformatics
      • 1.4.5 Label-Free Technology
    • 4.2 By Type, Global High Throughput Screening Market Size, 2019-2021

    5 Impact of Covid-19 on High Throughput Screening Segments, By Application

    • 5.1 Overview
      • 5.5.1 Pharmaceutical and Biotechnology Companies
      • 5.5.2 Academic and Government Institutes
      • 5.5.3 Contract Research Organizations
      • 5.5.4 Others
    • 5.2 By Application, Global High Throughput Screening Market Size, 2019-2021
      • 5.2.1 By Application, Global High Throughput Screening Market Size by Application, 2019-2021

    6 Geographic Analysis

    • 6.1 Introduction
    • 6.2 North America
      • 6.2.1 Macroeconomic Indicators of US
      • 6.2.2 US
      • 6.2.3 Canada
    • 6.3 Europe
      • 6.3.1 Macroeconomic Indicators of Europe
      • 6.3.2 Germany
      • 6.3.3 France
      • 6.3.4 UK
      • 6.3.5 Italy
    • 6.4 Asia-Pacific
      • 6.4.1 Macroeconomic Indicators of Asia-Pacific
      • 6.4.2 China
      • 6.4.3 Japan
      • 6.4.4 South Korea
      • 6.4.5 India
      • 6.4.6 ASEAN
    • 6.5 Rest of World
      • 6.5.1 Latin America
      • 6.5.2 Middle East and Africa

    7 Company Profiles

    • 7.1 Thermo Fisher
      • 7.1.1 Thermo Fisher Business Overview
      • 7.1.2 Thermo Fisher High Throughput Screening Quarterly Revenue, 2020
      • 7.1.3 Thermo Fisher High Throughput Screening Product Introduction
      • 7.1.4 Thermo Fisher Response to COVID-19 and Related Developments
    • 7.2 Agilent Technologies
      • 7.2.1 Agilent Technologies Business Overview
      • 7.2.2 Agilent Technologies High Throughput Screening Quarterly Revenue, 2020
      • 7.2.3 Agilent Technologies High Throughput Screening Product Introduction
      • 7.2.4 Agilent Technologies Response to COVID-19 and Related Developments
    • 7.3 Danaher
      • 7.3.1 Danaher Business Overview
      • 7.3.2 Danaher High Throughput Screening Quarterly Revenue, 2020
      • 7.3.3 Danaher High Throughput Screening Product Introduction
      • 7.3.4 Danaher Response to COVID-19 and Related Developments
    • 7.4 Perkinelmer
      • 7.4.1 Perkinelmer Business Overview
      • 7.4.2 Perkinelmer High Throughput Screening Quarterly Revenue, 2020
      • 7.4.3 Perkinelmer High Throughput Screening Product Introduction
      • 7.4.4 Perkinelmer Response to COVID-19 and Related Developments
    • 7.5 Tecan Group
      • 7.5.1 Tecan Group Business Overview
      • 7.5.2 Tecan Group High Throughput Screening Quarterly Revenue, 2020
      • 7.5.3 Tecan Group High Throughput Screening Product Introduction
      • 7.5.4 Tecan Group Response to COVID-19 and Related Developments
    • 7.6 Axxam
      • 7.6.1 Axxam Business Overview
      • 7.6.2 Axxam High Throughput Screening Quarterly Revenue, 2020
      • 7.6.3 Axxam High Throughput Screening Product Introduction
      • 7.6.4 Axxam Response to COVID-19 and Related Developments
    • 7.7 Bio-Rad Laboratories
      • 7.7.1 Bio-Rad Laboratories Business Overview
      • 7.7.2 Bio-Rad Laboratories High Throughput Screening Quarterly Revenue, 2020
      • 7.7.3 Bio-Rad Laboratories High Throughput Screening Product Introduction
      • 7.7.4 Bio-Rad Laboratories Response to COVID-19 and Related Developments
    • 7.8 Merck
      • 7.8.1 Merck Business Overview
      • 7.8.2 Merck High Throughput Screening Quarterly Revenue, 2020
      • 7.8.3 Merck High Throughput Screening Product Introduction
      • 7.8.4 Merck Response to COVID-19 and Related Developments
    • 7.9 Hamilton
      • 7.9.1 Hamilton Business Overview
      • 7.9.2 Hamilton High Throughput Screening Quarterly Revenue, 2020
      • 7.9.3 Hamilton High Throughput Screening Product Introduction
      • 7.9.4 Hamilton Response to COVID-19 and Related Developments
    • 7.10 Corning Incorporated
      • 7.10.1 Corning Incorporated Business Overview
      • 7.10.2 Corning Incorporated High Throughput Screening Quarterly Revenue, 2020
      • 7.10.3 Corning Incorporated High Throughput Screening Product Introduction
      • 7.10.4 Corning Incorporated Response to COVID-19 and Related Developments
    • 7.11 Biotek Instruments
      • 7.11.1 Biotek Instruments Business Overview
      • 7.11.2 Biotek Instruments High Throughput Screening Quarterly Revenue, 2020
      • 7.11.3 Biotek Instruments High Throughput Screening Product Introduction
      • 7.11.4 Biotek Instruments Response to COVID-19 and Related Developments
    • 7.12 Aurora Biomed
      • 7.12.1 Aurora Biomed Business Overview
      • 7.12.2 Aurora Biomed High Throughput Screening Quarterly Revenue, 2020
      • 7.12.3 Aurora Biomed High Throughput Screening Product Introduction
      • 7.12.4 Aurora Biomed Response to COVID-19 and Related Developments

    8 Key Findings

      9 Appendix

      • 9.1 About US

      This report covers market size and forecasts of High Throughput Screening, including the following market information:
      Global High Throughput Screening Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
      Global High Throughput Screening Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
      Global High Throughput Screening Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
      Global High Throughput Screening Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)

      Key market players
      Major competitors identified in this market include Thermo Fisher, Agilent Technologies, Danaher, Perkinelmer, Tecan Group, Axxam, Bio-Rad Laboratories, Merck, Hamilton, Corning Incorporated, Biotek Instruments, Aurora Biomed, etc.

      Based on the Region:
      Asia-Pacific (China, Japan, South Korea, India and ASEAN)
      North America (US and Canada)
      Europe (Germany, France, UK and Italy)
      Rest of World (Latin America, Middle East & Africa)

      Based on the Type:
      Cell-based Assays
      Lab-On-A-Chip
      Ultra-High-Throughput Screening
      Bioinformatics
      Label-Free Technology

      Based on the Application:
      Pharmaceutical and Biotechnology Companies
      Academic and Government Institutes
      Contract Research Organizations
      Others

      Buy now